As of 4:04pm ET
| +0.11 / +0.15%|
Medtronic Plc is engaged in the medical technology-alleviating pain, restoring health, and extending life for millions of people around the world. Its customers include hospitals, clinics, third-party health care providers, distributors, and other institutions, including governmental health care programs and group purchasing organizations. The company operates through four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group consist of three divisions : Cardiac Rhythm & Heart Failure, Coronary & Structural Heart and Aortic & Peripheral Vascular. The Minimally Invasive Technologies Group consists of two divisions: Surgical Solutions and Patient Monitoring and Recovery. The Restorative Therapies Group consists of four divisions: Spine, Neuromodulation, Surgical Technologies and Neurovascular. The Diabetes Group consists of three divisions: Intensive Insulin Management, Non-Intensive Diabetes Therapies and Diabetes Services & Solutions. The company was founded on January 26, 2015 and is headquartered in Dublin, Ireland.
|Omar S. Ishrak||Chairman & Chief Executive Officer|
|Gary Lee Ellis||EVP-Global Operations & Information Technology|
|Karen L. Parkhill||Chief Financial Officer & Executive Vice President|
|Richard E. Kuntz||Chief Scientific, Clinical & Regulatory Officer|
|Geoffrey Straub Martha||Executive VP & President-Restorative Therapies|